{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-027399","form_type":"8-K/A","ticker":"PRPH","cik":"0000868278","company_name":"ProPhase Labs, Inc.","filed_at":"2025-12-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.408484+00:00","generated_at":"2026-05-16T13:26:22.205119+00:00","sec_items":["5.03","8.01","9.01"],"event_type":"other","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"ProPhase Labs to effect 1-for-10 reverse stock split to maintain Nasdaq listing","bullets":["Stockholders approved reverse stock split on Nov 24, 2025; board approved Nov 30, 2025.","Certificate of Amendment filed Dec 2, 2025; split effective Dec 22, 2025 at 8:00 AM ET.","After split, approximately 5,768,951 shares of common stock will be outstanding.","No fractional shares; any fractional shares rounded up to whole share.","Reverse split intended to increase per-share price to meet Nasdaq continued listing requirements."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-027399","json":"https://secwatch.observer/filing/0001493152-25-027399.json","markdown":"https://secwatch.observer/filing/0001493152-25-027399.md","text":"https://secwatch.observer/filing/0001493152-25-027399.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/868278/000149315225027399/0001493152-25-027399-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/868278/000149315225027399/form8-ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:26:22.205119+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"053b22b1f3122c3a9e978c7c4fee635c1cad0d3a","claim":"ProPhase Labs, Inc.: Amended Certificate of Incorporation to effect a 1-for-10 reverse stock split of common stock (effective 2025-12-02).","evidence_excerpt":"On December 2, 2025, ProPhase Labs, Inc., a Delaware corporation (the “Company”), filed a Certificate of Amendment (the “Certificate of Amendment”) to its Certificate of Incorporation with the Secretary of State of the State of Delaware to effect a 1-for-10 reverse stock split of the Company’s issued and outstanding shares of common stock, par value $0.0005 per share (the “Common Stock”) (the “Reverse Stock Split”). The Certificate of Amendment became effective on December 2, 2025.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/868278/000149315225027399/0001493152-25-027399-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-12-02"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}